Microbot Medical will expand veterans' access to robotic surgery with LIBERTY

Microbot Medical Inc. announced a partnership with Lovell Government Services Inc. to work with federal healthcare systems. The collaboration aims to increase access to robotic surgery for U.S. Army veterans.

Partnership with Lovell Government Services

These are entities administered by the Veterans Health Administration (VHA), the Military Health System (MHS), and the U.S. Indigenous Health Service (IHS). Lovell Government Services will be Microbot's supplier in the Service-Disabled Veteran Owned Small Business (SDVOSB) category.

The company will serve these customers through federal contract systems.

“We are proud to partner with Microbot Medical,” said Chris Lovell, USMC Major and CEO of Lovell Government Services. “Together, we will expand access to innovative health technologies for our veterans, active duty military and Native Americans.”

“The LIBERTY endovascular robotic system is a major breakthrough in minimally invasive vascular care,” he added. “We intend to support its implementation in federal health care systems.”

Compact surgical system LIBERTY

Microbot Medical, based in Hingham, Massachusetts, offers LIBERTY, an endovascular robotic system for interventional physicians and hospitals. It is designed to improve the accuracy, safety and efficiency of procedures.

Unlike traditional manual technology, this surgical robot has a disposable, compact design and can be controlled remotely, the company says. LIBERTY is suitable for neurovascular, cardiovascular and peripheral vascular interventions.

Microbot adds: the system can reduce the cost of procedures and improve the overall quality of care.

In May, the Israeli Ministry of Health's AMAR division granted LIBERTY its first international market approval. Microbot went from limited to full commercial release.

Earlier this month, an academic center in North Carolina became the first to implement LIBERTY in the Southeast and Mid-Atlantic regions. Last week, the company announced that one of Michigan's largest health systems had also adopted the technology.

Availability through federal contracts

Pensacola, Fla.-based Lovell Government Services has been an SDVOSB provider since 2013. She has experience bringing suppliers to the government market. Microbot Medical's LIBERTY system will be included in Lovell's Federal Supply Schedule (FSS) contract.

The companies expect activation in the third quarter of 2026. LIBERTY will also be available through other federal procurement platforms: GSA Advantage, Defense Logistics Agency Electronic Catalog (ECAT), and Defense Allocation and Pricing Agreement (DAPA).

“I have represented the United States in two Olympics and am honored to team up with Lovell to ensure those serving in the military and their doctors have access to cutting-edge medical technology,” said Christina Bailey, vice president of US sales at Microbot. “Building on our commercial momentum, we believe this partnership will increase awareness and adoption of the technology across Lovell's extensive network.”

“Contract access is a key element of our commercial strategy,” she explained. “It gives customers a simplified purchasing path and confidence in product availability.”

Microbot expects that including products in the Lovell catalog will simplify the sales process and help government agencies meet purchasing goals from SDVOSB. The company serves thousands of public medical institutions throughout the country - 170 medical centers and many outpatient clinics. On average, one institution accounts for more than 200 peripheral endovascular interventions per year.